Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Influenza

Free Subscription Articles published in Eur J Epidemiol Retrieve available abstracts of 81 articles: HTML format

Single Articles

March 2024
1. ROTHMAN KJ
   The public-health mindset : Review of "The public health approach - population thinking from the black death to COVID-19" by Alfredo Morabia, Johns Hopkins University Press, 2023.
   Eur J Epidemiol. 2024;39:323-324.
   PubMed    
   
   
   February 2024
2. YANG L, Chen W, Chen D, He J, et al
   Cohort profile: the China surgery and anesthesia cohort (CSAC).
   Eur J Epidemiol. 2024;39:207-218.
   PubMed     Abstract available
   
   
   
3. NORSTROM T, Ramstedt M
   The impact of the COVID-19 pandemic on mortality in Sweden-Did it differ across socioeconomic groups?
   Eur J Epidemiol. 2024;39:137-145.
   PubMed     Abstract available
   
   
   December 2023
4. HARRISON EA
   Losing the Public, for Better or for Worse: A Lesson from John Everett Gordon (1890-1983) and John Rodman Paul (1893-1971).
   Eur J Epidemiol. 2023;38:1213-1217.
   PubMed     Abstract available
   
   
   
5. CHIOLERO A, Tancredi S, Ioannidis JPA
   Slow data public health.
   Eur J Epidemiol. 2023;38:1219-1225.
   PubMed     Abstract available
   
   
   November 2023
6. ANDERSON R
   Measuring mortality arising from the Covid-19 pandemic and the impact of vaccination.
   Eur J Epidemiol. 2023;38:1119-1123.
   PubMed    
   
   
   
7. JIA KM, Hanage WP, Lipsitch M, Johnson AG, et al
   Estimated preventable COVID-19-associated deaths due to non-vaccination in the United States.
   Eur J Epidemiol. 2023;38:1125-1128.
   PubMed     Abstract available
   
   
   
8. LEVITT M, Zonta F, Ioannidis JPA
   Excess death estimates from multiverse analysis in 2009-2021.
   Eur J Epidemiol. 2023;38:1129-1139.
   PubMed     Abstract available
   
   
   
9. ALICANDRO G, La Vecchia C, Islam N, Pizzato M, et al
   A comprehensive analysis of all-cause and cause-specific excess deaths in 30 countries during 2020.
   Eur J Epidemiol. 2023;38:1153-1164.
   PubMed     Abstract available
   
   
   August 2023
10. LIN S, Gao X, Degenhardt F, Qian Y, et al
    Genome-wide epistasis study highlights genetic interactions influencing severity of COVID-19.
    Eur J Epidemiol. 2023;38:883-889.
    PubMed     Abstract available
    
    
    
11. NORREDAM M, Islamoska S, Petersen JH, Benfield T, et al
    COVID-19 mortality and use of intensive care among ethnic minorities - a national register-based Danish population study.
    Eur J Epidemiol. 2023;38:891-899.
    PubMed     Abstract available
    
    
    May 2023
12. ANDERSEN MP, Mills EHA, Meddis A, Sorensen KK, et al
    All-cause mortality among Danish nursing home residents before and during the COVID-19 pandemic: a nationwide cohort study.
    Eur J Epidemiol. 2023;38:523-531.
    PubMed     Abstract available
    
    
    April 2023
13. BUTTIA C, Llanaj E, Raeisi-Dehkordi H, Kastrati L, et al
    Prognostic models in COVID-19 infection that predict severity: a systematic review.
    Eur J Epidemiol. 2023;38:355-372.
    PubMed     Abstract available
    
    
    March 2023
14. POZO-MARTIN F, Beltran Sanchez MA, Muller SA, Diaconu V, et al
    Comparative effectiveness of contact tracing interventions in the context of the COVID-19 pandemic: a systematic review.
    Eur J Epidemiol. 2023;38:243-266.
    PubMed     Abstract available
    
    
    
15. BEUKENHORST AL, Koch CM, Hadjichrysanthou C, Alter G, et al
    SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategies.
    Eur J Epidemiol. 2023;38:237-242.
    PubMed     Abstract available
    
    
    
16. BELL M, Ekbom A, Linder M
    COVID-19 and comedications in atrial fibrillation-a case-control study in Stockholm.
    Eur J Epidemiol. 2023;38:301-311.
    PubMed     Abstract available
    
    
    February 2023
17. BOWYER RCE, Huggins C, Toms R, Shaw RJ, et al
    Characterising patterns of COVID-19 and long COVID symptoms: evidence from nine UK longitudinal studies.
    Eur J Epidemiol. 2023;38:199-210.
    PubMed     Abstract available
    
    
    January 2023
18. RODIAH I, Vanella P, Kuhlmann A, Jaeger VK, et al
    Age-specific contribution of contacts to transmission of SARS-CoV-2 in Germany.
    Eur J Epidemiol. 2023;38:39-58.
    PubMed     Abstract available
    
    
    
19. ANGELINI M, Teglia F, Astolfi L, Casolari G, et al
    Decrease of cancer diagnosis during COVID-19 pandemic: a systematic review and meta-analysis.
    Eur J Epidemiol. 2023;38:31-38.
    PubMed     Abstract available
    
    
    December 2022
20. JOYAL-DESMARAIS K, Stojanovic J, Kennedy EB, Enticott JC, et al
    How well do covariates perform when adjusting for sampling bias in online COVID-19 research? Insights from multiverse analyses.
    Eur J Epidemiol. 2022;37:1233-1250.
    PubMed     Abstract available
    
    
    November 2022
21. SIEURIN J, Branden G, Magnusson C, Hergens MP, et al
    A population-based cohort study of sex and risk of severe outcomes in covid-19.
    Eur J Epidemiol. 2022;37:1159-1169.
    PubMed     Abstract available
    
    
    October 2022
22. SAMUEL A
    Re: Carrat et al. Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based "CONSTANCES" cohort.
    Eur J Epidemiol. 2022;37:1083-1084.
    PubMed    
    
    
    
23. BERGHOFER A, Rotter G, Pankert J, Icke K, et al
    SARS-CoV-2 infections in professional orchestra and choir musicians-a prospective cohort study.
    Eur J Epidemiol. 2022;37:1061-1070.
    PubMed     Abstract available
    
    
    
24. BANHOLZER N, Lison A, Ozcelik D, Stadler T, et al
    The methodologies to assess the effectiveness of non-pharmaceutical interventions during COVID-19: a systematic review.
    Eur J Epidemiol. 2022;37:1003-1024.
    PubMed     Abstract available
    
    
    
25. MATHIEU C, Pambrun E, Benard-Laribiere A, Noize P, et al
    Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort study.
    Eur J Epidemiol. 2022;37:1049-1059.
    PubMed     Abstract available
    
    
    
26. EBELING M, Acosta E, Caswell H, Meyer AC, et al
    Years of life lost during the Covid-19 pandemic in Sweden considering variation in life expectancy by level of geriatric care.
    Eur J Epidemiol. 2022;37:1025-1034.
    PubMed     Abstract available
    
    
    
27. BUCYIBARUTA G, Blangiardo M, Konstantinoudis G
    Community-level characteristics of COVID-19 vaccine hesitancy in England: A nationwide cross-sectional study.
    Eur J Epidemiol. 2022;37:1071-1081.
    PubMed     Abstract available
    
    
    
28. MCDONALD SA, Lagerweij GR, de Boer P, de Melker HE, et al
    The estimated disease burden of acute COVID-19 in the Netherlands in 2020, in disability-adjusted life-years.
    Eur J Epidemiol. 2022;37:1035-1047.
    PubMed     Abstract available
    
    
    September 2022
29. IOANNIDIS JPA
    Estimating conditional vaccine effectiveness.
    Eur J Epidemiol. 2022;37:885-890.
    PubMed     Abstract available
    
    
    
30. JOLLANT F, Blanc-Brisset I, Cellier M, Ambar Akkaoui M, et al
    Temporal trends in calls for suicide attempts to poison control centers in France during the COVID-19 pandemic: a nationwide study.
    Eur J Epidemiol. 2022;37:901-913.
    PubMed     Abstract available
    
    
    August 2022
31. GARCIA-ALBENIZ X, Del Amo J, Polo R, Morales-Asencio JM, et al
    Systematic review and meta-analysis of randomized trials of hydroxychloroquine for the prevention of COVID-19.
    Eur J Epidemiol. 2022;37:789-796.
    PubMed     Abstract available
    
    
    
32. SCHONS M, Pilgram L, Reese JP, Stecher M, et al
    The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics.
    Eur J Epidemiol. 2022;37:849-870.
    PubMed     Abstract available
    
    
    
33. GELDSETZER P, Mukama T, Jawad NK, Riffe T, et al
    Sex differences in the mortality rate for coronavirus disease 2019 compared to other causes of death: an analysis of population-wide data from 63 countries.
    Eur J Epidemiol. 2022;37:797-806.
    PubMed     Abstract available
    
    
    June 2022
34. NARRES M, Claessen H, Kvitkina T, Rosenbauer J, et al
    Hospitalisation rate and mortality among people with and without diabetes during the COVID-19 pandemic year 2020.
    Eur J Epidemiol. 2022;37:587-590.
    PubMed     Abstract available
    
    
    May 2022
35. VERBERK JDM, de Hoog MLA, Westerhof I, van Goethem S, et al
    Transmission of SARS-CoV-2 within households: a remote prospective cohort study in European countries.
    Eur J Epidemiol. 2022;37:549-561.
    PubMed     Abstract available
    
    
    
36. CASPERSEN IH, Magnus P, Trogstad L
    Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort.
    Eur J Epidemiol. 2022;37:539-548.
    PubMed     Abstract available
    
    
    March 2022
37. LEVIN AT, Jylhava J, Religa D, Shallcross L, et al
    COVID-19 prevalence and mortality in longer-term care facilities.
    Eur J Epidemiol. 2022;37:227-234.
    PubMed     Abstract available
    
    
    
38. AXFORS C, Ioannidis JPA
    Infection fatality rate of COVID-19 in community-dwelling elderly populations.
    Eur J Epidemiol. 2022;37:235-249.
    PubMed     Abstract available
    
    
    February 2022
39. HERGENS MP, Bell M, Haglund P, Sundstrom J, et al
    Risk factors for COVID-19-related death, hospitalization and intensive care: a population-wide study of all inhabitants in Stockholm.
    Eur J Epidemiol. 2022;37:157-165.
    PubMed     Abstract available
    
    
    
40. HVIDE HK, Johnsen J
    COVID-19 and mental health: a longitudinal population study from Norway.
    Eur J Epidemiol. 2022;37:167-172.
    PubMed     Abstract available
    
    
    December 2021
41. COLEMAN T, Sarian A, Grad S
    Re: Subramanian and Kumar. Vaccination rates and COVID-19 cases.
    Eur J Epidemiol. 2021;36:1245-1246.
    PubMed    
    
    
    
42. MULOT M, Segalas C, Leyrat C, Besancon L, et al
    Re: Subramanian and Kumar. Vaccination rates and COVID-19 cases.
    Eur J Epidemiol. 2021;36:1243-1244.
    PubMed    
    
    
    
43. SUBRAMANIAN SV, Kumar A
    The Authors' Reply: Need for a multi-pronged population-level strategy to manage SARS-CoV-2 infection.
    Eur J Epidemiol. 2021;36:1247-1251.
    PubMed    
    
    
    
44. GIANICOLO E, Wollschlager D, Blettner M
    Re: Subramanian and Kumar. Vaccination rates and COVID-19 cases.
    Eur J Epidemiol. 2021;36:1241-1242.
    PubMed    
    
    
    
45. BJORK J, Modig K, Kahn F, Ahlbom A, et al
    Revival of ecological studies during the COVID-19 pandemic.
    Eur J Epidemiol. 2021;36:1225-1229.
    PubMed    
    
    
    
46. WOLLSCHLAGER D, Gianicolo E, Blettner M, Hamann R, et al
    Association of COVID-19 mortality with COVID-19 vaccination rates in Rhineland-Palatinate (Germany) from calendar week 1 to 20 in the year 2021: a registry-based analysis.
    Eur J Epidemiol. 2021;36:1231-1236.
    PubMed     Abstract available
    
    
    
47. SUBRAMANIAN SV, Kumar A
    Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States.
    Eur J Epidemiol. 2021;36:1237-1240.
    PubMed    
    
    
    July 2021
48. ESPENHAIN L, Tribler S, Svaerke Jorgensen C, Holm Hansen C, et al
    Prevalence of SARS-CoV-2 antibodies in Denmark: nationwide, population-based seroepidemiological study.
    Eur J Epidemiol. 2021;36:715-725.
    PubMed     Abstract available
    
    
    
49. BELLUCO S, Mancin M, Marzoli F, Bortolami A, et al
    Prevalence of SARS-CoV-2 RNA on inanimate surfaces: a systematic review and meta-analysis.
    Eur J Epidemiol. 2021;36:685-707.
    PubMed     Abstract available
    
    
    
50. GOUDSMIT J, van den Biggelaar AHJ, Koudstaal W, Hofman A, et al
    Immune age and biological age as determinants of vaccine responsiveness among elderly populations: the Human Immunomics Initiative research program.
    Eur J Epidemiol. 2021;36:753-762.
    PubMed     Abstract available
    
    
    
51. MCDONALD SA, Miura F, Vos ERA, van Boven M, et al
    Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of nationwide serosurvey data in the Netherlands.
    Eur J Epidemiol. 2021;36:735-739.
    PubMed     Abstract available
    
    
    
52. TELLE K, Jorgensen SB, Hart R, Greve-Isdahl M, et al
    Secondary attack rates of COVID-19 in Norwegian families: a nation-wide register-based study.
    Eur J Epidemiol. 2021;36:741-748.
    PubMed     Abstract available
    
    
    
53. REICHER S, Ratzon R, Ben-Sahar S, Hermoni-Alon S, et al
    Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel.
    Eur J Epidemiol. 2021;36:727-734.
    PubMed     Abstract available
    
    
    June 2021
54. IOANNIDIS JPA
    Over- and under-estimation of COVID-19 deaths.
    Eur J Epidemiol. 2021;36:581-588.
    PubMed     Abstract available
    
    
    
55. LICHER S, Terzikhan N, Splinter MJ, Velek P, et al
    Design, implementation and initial findings of COVID-19 research in the Rotterdam Study: leveraging existing infrastructure for population-based investigations on an emerging disease.
    Eur J Epidemiol. 2021;36:649-654.
    PubMed     Abstract available
    
    
    
56. LUNDBERG JO, Zeberg H
    Longitudinal variability in mortality predicts COVID-19 deaths.
    Eur J Epidemiol. 2021;36:599-603.
    PubMed     Abstract available
    
    
    
57. NAFILYAN V, Islam N, Mathur R, Ayoubkhani D, et al
    Ethnic differences in COVID-19 mortality during the first two waves of the Coronavirus Pandemic: a nationwide cohort study of 29 million adults in England.
    Eur J Epidemiol. 2021;36:605-617.
    PubMed     Abstract available
    
    
    
58. POZO-MARTIN F, Weishaar H, Cristea F, Hanefeld J, et al
    The impact of non-pharmaceutical interventions on COVID-19 epidemic growth in the 37 OECD member states.
    Eur J Epidemiol. 2021;36:629-640.
    PubMed     Abstract available
    
    
    
59. FERENCI T
    Different approaches to quantify years of life lost from COVID-19.
    Eur J Epidemiol. 2021;36:589-597.
    PubMed     Abstract available
    
    
    
60. SCHMITZ T, Meisinger C, Kirchberger I, Thilo C, et al
    Impact of COVID-19 pandemic lockdown on myocardial infarction care.
    Eur J Epidemiol. 2021;36:619-627.
    PubMed     Abstract available
    
    
    May 2021
61. BOTTCHER L, D'Orsogna MR, Chou T
    Using excess deaths and testing statistics to determine COVID-19 mortalities.
    Eur J Epidemiol. 2021;36:545-558.
    PubMed     Abstract available
    
    
    
62. BATTY GD, Deary IJ, Gale CR
    Pre-pandemic cognitive function and COVID-19 mortality: prospective cohort study.
    Eur J Epidemiol. 2021;36:559-564.
    PubMed     Abstract available
    
    
    April 2021
63. BUSHMAN M, Worby C, Chang HH, Kraemer MUG, et al
    Transmission of SARS-CoV-2 before and after symptom onset: impact of nonpharmaceutical interventions in China.
    Eur J Epidemiol. 2021;36:429-439.
    PubMed     Abstract available
    
    
    
64. DE SOUZA FSH, Hojo-Souza NS, da Silva CM, Guidoni DL, et al
    Second wave of COVID-19 in Brazil: younger at higher risk.
    Eur J Epidemiol. 2021;36:441-443.
    PubMed    
    
    
    March 2021
65. BERGMAN J, Ballin M, Nordstrom A, Nordstrom P, et al
    Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study.
    Eur J Epidemiol. 2021;36:287-298.
    PubMed     Abstract available
    
    
    
66. TERZIKHAN N, Hofman A, Goudsmit J, Ikram MA, et al
    External validity of phase III trials on vaccines against SARS-CoV-2 to a middle-aged and elderly Western European population.
    Eur J Epidemiol. 2021;36:319-324.
    PubMed     Abstract available
    
    
    
67. ELLIOTT J, Bodinier B, Whitaker M, Delpierre C, et al
    COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors.
    Eur J Epidemiol. 2021;36:299-309.
    PubMed     Abstract available
    
    
    
68. FAN X, Yin C, Wang J, Yang M, et al
    Pre-diagnostic circulating concentrations of insulin-like growth factor-1 and risk of COVID-19 mortality: results from UK Biobank.
    Eur J Epidemiol. 2021;36:311-318.
    PubMed     Abstract available
    
    
    February 2021
69. PEARCE N, Vandenbroucke JP
    Arguments about face masks and Covid-19 reflect broader methodologic debates within medical science.
    Eur J Epidemiol. 2021;36:143-147.
    PubMed     Abstract available
    
    
    
70. SKJEFTE M, Ngirbabul M, Akeju O, Escudero D, et al
    COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries.
    Eur J Epidemiol. 2021;36:197-211.
    PubMed     Abstract available
    
    
    
71. ACCORSI EK, Qiu X, Rumpler E, Kennedy-Shaffer L, et al
    How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19.
    Eur J Epidemiol. 2021;36:179-196.
    PubMed     Abstract available
    
    
    
72. CARRAT F, Figoni J, Henny J, Desenclos JC, et al
    Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based "CONSTANCES" cohort.
    Eur J Epidemiol. 2021;36:219-222.
    PubMed     Abstract available
    
    
    
73. GIANICOLO EAL, Russo A, Buchler B, Taylor K, et al
    Gender specific excess mortality in Italy during the COVID-19 pandemic accounting for age.
    Eur J Epidemiol. 2021;36:213-218.
    PubMed     Abstract available
    
    
    January 2021
74. PEARCE N, Moirano G, Maule M, Kogevinas M, et al
    Does death from Covid-19 arise from a multi-step process?
    Eur J Epidemiol. 2021;36:1-9.
    PubMed     Abstract available
    
    
    December 2020
75. LEVIN AT, Hanage WP, Owusu-Boaitey N, Cochran KB, et al
    Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications.
    Eur J Epidemiol. 2020;35:1123-1138.
    PubMed     Abstract available
    
    
    November 2020
76. GOMEZ-OCHOA SA, Franco OH
    COVID-19: facts and failures, a tale of two worlds.
    Eur J Epidemiol. 2020;35:991-994.
    PubMed    
    
    
    
77. CATALANO R, Casey JA, Bruckner TA, Gemmill A, et al
    Non-COVID-19 deaths after social distancing in Norway.
    Eur J Epidemiol. 2020;35:1021-1024.
    PubMed     Abstract available
    
    
    
78. HANAGE WP, Testa C, Chen JT, Davis L, et al
    COVID-19: US federal accountability for entry, spread, and inequities-lessons for the future.
    Eur J Epidemiol. 2020;35:995-1006.
    PubMed     Abstract available
    
    
    
79. MILLS EHA, Moller AL, Gnesin F, Zylyftari N, et al
    National all-cause mortality during the COVID-19 pandemic: a Danish registry-based study.
    Eur J Epidemiol. 2020;35:1007-1019.
    PubMed     Abstract available
    
    
    
80. HUANG J, Teoh JY, Wong SH, Wong MCS, et al
    The potential impact of previous exposure to SARS or MERS on control of the COVID-19 pandemic.
    Eur J Epidemiol. 2020;35:1099-1103.
    PubMed     Abstract available
    
    
    June 2020
81. LIPSITCH M
    Good science is good science: we need specialists, not sects.
    Eur J Epidemiol. 2020;35:519-522.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.